Related Experiment Video
Updated: Jan 24, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Hyperuricemia in Living Donor Kidney Transplantation Patients During Mizoribine Administration Caused Mainly by
Yi Shi1, Hang Liu2, Xin-Guo Chen3
1Department of Urology, Beijing Tsinghua Changgung Hospital, Beijing, China; Organ Transplantation Center, Tianjin First Center Hospital, Tianjin, China.
Background:
Although mizoribine (MZR) is used as an immunosuppressant after renal transplantation, the occurrence of hyperuricemia has been reported. The onset of hyperuricemia is often observed within the first several months after surgery. Since MZR is a renal excretion-type drug excreted as an unchanged drug from the kidneys, MZR blood concentrations may rise due to the influence of renal function. We investigated whether the onset of hyperuricemia after MZR administration was associated with the direct effect of a change in renal function.
Methods:
Serum uric acid (serum UA), serum creatinine (sCr), serum β2-microglobulin (serum β2-MG), and serum cystatin C (serum Cys-C) were measured for about 3 months in 22 subjects. Correlation coefficients were calculated using the change rates of serum UA and sCr (Δ serum UA, Δ sCr), serum UA and serum β2-MG (Δ serum UA, Δ serum β2-MG), and serum UA and serum Cys-C (Δ serum UA, Δ serum Cys-C) at the onset of hyperuricemia.
Results:
The correlation coefficients between Δ serum UA and Δ sCr, Δ serum UA and Δ serum β2-MG, and Δ serum UA and Δ serum Cys-C were 0.723 (P < .001), 0.863 (P < .001) and 0.548 (P < .001), respectively. Further, serum UA and sCr level reached their highest peak on the same day after MZR administration, and the behavior was mostly consistent.
Conclusion:
It was suggested that hyperuricemia occurred about 3 months after MZR administration due mainly to temporary changes in kidney function.
Insights
Mizoribine (MZR) can cause hyperuricemia in transplant patients, often within months. This study suggests temporary kidney function changes, not MZR levels, are the primary cause of elevated uric acid.
Area of Science:
- Nephrology
- Pharmacology
- Immunology
Background:
- Mizoribine (MZR) is an immunosuppressant used post-renal transplantation.
- Hyperuricemia is a reported side effect of MZR, typically emerging within months of administration.
- MZR is renally excreted, raising concerns about its blood concentration and kidney function.
Purpose of the Study:
- To investigate the association between changes in renal function and the onset of hyperuricemia in patients receiving MZR.
- To determine if MZR's pharmacokinetic profile, influenced by renal function, directly contributes to hyperuricemia.
Main Methods:
- Serum uric acid (UA), creatinine (sCr), β2-microglobulin (β2-MG), and cystatin C (Cys-C) were monitored for approximately 3 months in 22 subjects.
- Correlation coefficients were calculated for changes in serum UA against changes in sCr, β2-MG, and Cys-C at the onset of hyperuricemia.
Main Results:
- Strong positive correlations were observed between changes in serum UA and changes in sCr (r=0.723), β2-MG (r=0.863), and Cys-C (r=0.548), all statistically significant (P < .001).
- Serum UA and sCr levels peaked concurrently after MZR administration, indicating a consistent pattern.
- The data suggests a direct relationship between declining renal function markers and rising uric acid levels.
Conclusions:
- Hyperuricemia following MZR administration is primarily attributed to temporary alterations in kidney function.
- These renal function changes, rather than MZR concentration itself, appear to be the main driver of elevated uric acid levels.
- Monitoring kidney function is crucial for managing hyperuricemia in MZR-treated patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Structure
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...

